{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:14:35Z","timestamp":1783566875218,"version":"3.55.0"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":5046,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1995,7]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> It has been recognized in recent years that some patients with myelodysplastic syndromes (MDS) develop immune\u2010mediated complications (IMC), but little is known about the correlations to MDS\u2010specific disease features. In a retrospective study of 82 MDS patients, we identified 10 (12%) with IMC (group A) and compared them to the remaining 72 cases (group B). Group A consisted of 5 patients with biopsy\u2010verified skin vasculitis and 1 case each with temporal arteritis\/polymyalgia rheumatica, necrotising panniculitis, Hashimoto's thyroiditis, autoimmune thrombocytopenia, and Sweet's syndrome. Survival times, sex ratio and distribution of MDS subtypes were similar in the two groups. The patients in group A were younger than those in group B (median 66 <jats:italic>vs.<\/jats:italic> 76 years, p&lt;0.01). Four patients (40%) in group A had a history of previous genotoxic therapy for malignant disorders. The bone marrow karyotype was evaluated in 62 patients. Clonal chromosomal abnormalities were found more frequently in Group A than in group B (8\/9 <jats:italic>vs.<\/jats:italic> 26\/53, p = 0.03), and complex karyotypes, i.e., three or more aberrations, were also observed to be more common in group A (3\/9 <jats:italic>vs.<\/jats:italic> 8\/53). The results indicate that IMC preferentially develop in patients with secondary MDS, in younger MDS cases, and in patients with cytogenetic abnormalities.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1995.tb00231.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T04:56:23Z","timestamp":1279428983000},"page":"42-48","source":"Crossref","is-referenced-by-count":90,"title":["Immune\u2010mediated complications in patients with myelodysplastic syndromes \u2013 clinical and cytogenetic features"],"prefix":"10.1111","volume":"55","author":[{"given":"Rolf","family":"Billstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hel\u00e9ne","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Mitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30329-0"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08238.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.V80.7.1774.1774","article-title":"Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: Analysis by X\u2010linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene","volume":"80","author":"Kamp H.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1182\/blood.V81.7.1849.1849","article-title":"Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini\u2010repeat sequences on highly purified cell fractions","volume":"81","author":"Kroef MJ","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood.V83.10.2809.2809","article-title":"Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells","volume":"83","author":"White NJ","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08080.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870100204"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.7.1823.1823"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood.V75.9.1770.1770","article-title":"Clonal studies in the myelodysplastic syndromes using X\u2010linked restriction fragment length polymorphism","volume":"75","author":"Tefferi A.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.V73.1.248.248","article-title":"Clonal analysis of myelodysplastic syndromes: Evidence of multipotent stem cell origin","volume":"73","author":"Janssen JWG","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb07504.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1991.tb01571.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880315)61:6<1075::AID-CNCR2820610604>3.0.CO;2-E"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02597.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb04369.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07818.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309148503"},{"key":"e_1_2_1_19_2","first-page":"721","article-title":"Rheumatic manifestations in myelodysplastic syndromes","volume":"18","author":"Castro M.","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450112"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08030.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830430318"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(92)90035-C"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1992.tb00924.x"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1992.tb03987.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03083.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00442.x"},{"key":"e_1_2_1_28_2","first-page":"500","article-title":"Panniculitis and myelodysplasia: Report of 2 cases","volume":"2","author":"Lesprit P.","year":"1993","journal-title":"Eur J Med"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1991.tb04873.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb02771.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(92)90095-O"},{"key":"e_1_2_1_32_2","volume-title":"Supplement to an International System for Human Cytogenetic Nomenclature","author":"ISCN 1991.","year":"1991"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1991.tb00556.x"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(87)90093-8"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb00207.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.12.1887"},{"key":"e_1_2_1_37_2","first-page":"1670","volume-title":"Harrison's Principles of Internal Medicine","author":"Fauci AS","year":"1994"},{"key":"e_1_2_1_38_2","first-page":"39","article-title":"Vasculitis associated with malignancy","volume":"4","author":"Mertz LE","year":"1992","journal-title":"Curr Opin Rheumatol"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/100.3.276"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb01340.x"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1992.11718261"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb05852.x"},{"key":"e_1_2_1_43_2","volume-title":"Cancer Cytogenetics","author":"Heim S.","year":"1995"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1995.tb00231.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1995.tb00231.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T04:43:09Z","timestamp":1698381789000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1995.tb00231.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,7]]}},"alternative-id":["10.1111\/j.1600-0609.1995.tb00231.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1995.tb00231.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7]]}}}